Last edition
News about "varegacestat"
EMA Validates Immunome's Varegacestat Application for Desmoid Tumours
Immunome has secured EMA validation for its varegacestat marketing application for adults with desmoid tumours, supported by positive Phase 3 RINGSIDE trial results.
Varegacestat | 03/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members